StatFinn

Espoo, Finland Founded: 2005 • Age: 21 yrs Acquired By IQVIA
CRO offering data management, biostatistics, and statistical programming services

About StatFinn

StatFinn is a Healthcare company based in Espoo (Finland) founded in 2005, and was acquired by IQVIA in May 2018. CRO offering data management, biostatistics, and statistical programming services. StatFinn has completed 1 acquisition, including EPID Research. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Functional Services.

Company details

StatFinn was founded in 2005 and is based in Espoo, Finland. A merger with EPID Research occurred in January 2017. Services in data management and biostatistics are provided for drug development, covering phases from planning to close-out. Consulting, planning, and execution support early-stage drug development. These services extend to clinical and non-clinical trials, medical device projects, the food industry, and academic research.

Key Metrics

Investors in StatFinn

StatFinn has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include IQVIA.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Clinical research and commercialization solutions are provided for healthcare.
1982iqvia.comDurham, United States
Premium access

Investor details for StatFinn

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Investments & Acquisitions by StatFinn

StatFinn has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include EPID Research.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Pharmacoepidemiological research services are offered to life sciences firms.
epidresearch.comEspoo, Finland2010Jan 2017β€’β€’β€’β€’
Premium access

Complete acquisition details for StatFinn

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of StatFinn

3 dated milestones of StatFinn across 13 years, from founding to its latest funding, stage changes and deals.

  1. Founded StatFinn is founded.
  2. Acquisition Acquires EPID Research.
  3. Exit Acquired by IQVIA.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about StatFinn

StatFinn was founded in 2005.

StatFinn is headquartered in Espoo, Finland.

StatFinn was founded in 2005 and is based in Espoo, Finland. A merger with EPID Research occurred in January 2017. Services in data management and biostatistics are provided for drug development, covering phases from planning to close-out. Consulting, planning, and execution support early-stage drug development. These services extend to clinical and non-clinical trials, medical device projects, the food industry, and academic research.

StatFinn has made 1 acquisition, including EPID Research.

StatFinn has 1 investor. Key investors include IQVIA.

Yes. StatFinn was acquired by IQVIA in May 2018.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available